Here, we demonstrate that eIF4Ai deprive CLL cells of both survival and growth promoting effectors induced following BCR activation and provide important new insight into the mechanisms of action of these compounds. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.